BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 12, 2026
Home » Blogs » BioWorld MedTech Perspectives » Keeping up, staying connected

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology

Keeping up, staying connected

Nov. 11, 2011
By Amanda Pedersen

Recently I posted a blog here about my observations of the medical device space over the last five years and how it has changed during my five-year tenure at Medical Device Daily. Like the industry, we too have changed a great deal since I joined the MDD staff in October 2006.

The first big change during that timeframe is the launching of Medical Device Daily Perspectives, our free, weekly e-zine, MDD Perspectives offering viewpoints on developments within the med-tech industry. In that, we aim to go beyond the news to provide you with a fresh outlook on the companies, trends, people and events taking place in the industry today. It goes beyond the who, what, where, when, how, and why to help you see understand how it affects you and why you should care.

Not long after MDD Perspectives launched, we saw an opportunity to bring you news as it is still developing, giving you a sneak peak at what to expect in our next daily issue of MDD. With that, the Medical Device Daily Midday Report was born. It's an email sent to our subscribers typically once a day (more in the event of late breaking news) offering a snippet of what we are working on for the next day’s issue. We figured we owed our subscribers that little heads-up on what to look for the following day.

As social networking has rapidly taken on a life of its own over the past couple of years, we knew we needed to engage our readers through sites like Facebook and Twitter in an effort to interact with you and also give you yet another venue of finding out what is happening at that very moment – tomorrow’s headlines today, so to speak, in 140 characters or less!

Earlier this year we launched the Medical Device Daily Perspectives Blog site. Similar to the weekly e-zine, this site brings you critical news, analysis, debates, commentary and camaraderie related to the med-tech industry.

We have worked hard over the last half a decade to keep up with the way information technology has changed and to deliver the news to you more immediately than ever before.

Of course there is always room for improvement and we do challenge ourselves on a regular basis to do better.

More blogs. More tweets. More breaking news alerts.

We’re always open to new ideas, so if there is something you would like to see more of, less of, or just think we should try doing differently, don’t be shy! Drop us an e-mail, Facebook message, Tweet to us, or simply post a comment here on our blog site.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 10, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent

    BioWorld Science
    Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing